NutriBand (NTRB) Notes Payables (2017 - 2026)

NutriBand's (NTRB) quarterly Notes Payables came in at $128871.0 in Q1 2026, up 0.57% year-on-year from $128144.0 in Q1 2025, and little changed quarter-over-quarter from $128619.0 in Q4 2025.

NutriBand (NTRB) Notes Payables (2017 - 2026) Analysis & Trends

NutriBand has disclosed Notes Payables across 10 years of filings, most recently posting $128871.0 for Q1 2026.

  • Notes Payables for Q1 2026 came in at $128871.0, up 0.57% year-over-year; the trailing twelve-month figure through Jan 2026 was $128871.0 (up 0.57% YoY), and the FY2026 annual result was $128871.0, up 0.57% from the prior year.
  • Notes Payables came in at $128871.0 for Q1 2026 at NutriBand, roughly flat from $128619.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $128871.0 in Q1 2026 to a low of $14119.0 in Q1 2022.
  • The 5-year median for Notes Payables is $126709.0 (2023), against an average of $82627.2.
  • Across the five-year window, Notes Payables tumbled 98.99% in 2022 and jumped 619.0% in 2023, its largest moves.
  • NutriBand's Notes Payables stood at $21335.0 in 2022, then soared by 494.85% to $126912.0 in 2023, then rose by 0.78% to $127900.0 in 2024, then rose by 0.56% to $128619.0 in 2025, then climbed by 0.2% to $128871.0 in 2026.
  • The last three Notes Payables figures came in at $128871.0 (Q1 2026), $128619.0 (Q4 2025), and $56490.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 NutriBand 41.91 Mn 37.33 Mn 88,941.00

Historic Data

Download Data
DateValue
Jan 31, 2026 128,871.00
Oct 31, 2025 128,619.00
Jul 31, 2025 56,490.00
Apr 30, 2025 128,391.00
Jan 31, 2025 128,144.00
Oct 31, 2024 127,900.00
Jul 31, 2024 127,659.00
Apr 30, 2024 81,290.00
Jan 31, 2024 127,183.00
Oct 31, 2023 126,912.00
Jul 31, 2023 126,709.00
Apr 30, 2023 19,931.00
Jan 31, 2023 19,740.00
Oct 31, 2022 21,335.00
Jul 31, 2022 17,623.00
Apr 30, 2022 23,746.00
Jan 31, 2022 14,119.00
Oct 31, 2021 14,119.00
Jul 31, 2021 14,119.00
Apr 30, 2021 14,060.00